Missing, Inconsistent, and Other—A Call to Improve Transgender Representation in Oncology Research

Borah, Luca; Lane, Megan; Nathan, Hari

doi:10.1001/jamaoncol.2023.1344

Cited by 4 publications

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other groups, for example, such as adolescents and young adults, often experience lack of availability and access to clinical trial programs 14,15 . Sexual and gender minorities including those from the lesbian, gay, bisexual, transgender, and queer (LGBTQ+) populations are regularly impeded by societal stigma and discrimination, which leads to decreased cancer clinical trial visibility, access, and participation and inclusion 16,17 . An overarching barrier among all underserved populations is the lack of public awareness and clinical trial understanding.…”

Section: Patient-level Considerations and Solutionsmentioning

confidence: 99%

“…14,15 Sexual and gender minorities including those from the lesbian, gay, bisexual, transgender, and queer (LGBTQ+) populations are regularly impeded by societal stigma and discrimination, which leads to decreased cancer clinical trial visibility, access, and participation and inclusion. 16,17 An overarching barrier among all underserved populations is the lack of public awareness and clinical trial understanding. Although the issues and solutions discussed in this article are mainly that which fit in a generalized experience of racial and ethnic marginalized groups, we recognize that the challenges each group experiences are unique and acknowledge that effective and sustainable solutions must take these specific experiences into consideration.…”

Section: Patient-level Considerations and Solutionsmentioning

confidence: 99%

See 1 more Smart Citation

Diversity in Cancer Care

Akimoto,

Taparra,

Brown

et al. 2023

Cancer J

View full text Add to dashboard Cite

Access to and participation in cancer clinical trials determine whether such data are applicable, feasible, and generalizable among populations. The lack of inclusion of low-income and marginalized populations limits generalizability of the critical data guiding novel therapeutics and interventions used globally. Such lack of cancer clinical trial equity is troubling, considering that the populations frequently excluded from these trials are those with disproportionately higher cancer morbidity and mortality rates. There is an urgency to increase representation of marginalized populations to ensure that effective treatments are developed and equitably applied. Efforts to ameliorate these clinical trial inclusion disparities are met with a slew of multifactorial and multilevel challenges. We aim to review these challenges at the patient, clinician, system, and policy levels. We also highlight and propose solutions to inform future efforts to achieve cancer health equity.

show abstract

Section: Patient-level Considerations and Solutionsmentioning

confidence: 99%

Section: Patient-level Considerations and Solutionsmentioning

confidence: 99%

Diversity in Cancer Care

Akimoto,

Taparra,

Brown

et al. 2023

Cancer J

View full text Add to dashboard Cite

show abstract

“Prostatectomy after gender-affirming vaginoplasty for a transgender woman with prostate cancer”

Blasdel,

Borah,

Navarrete

et al. 2024

Urology Case Reports

View full text Add to dashboard Cite

Considerations for the Treatment of Sexual and Gender Minority Individuals in Colon and Rectal Surgery

Roblee,

Jacobson,

Lane

et al. 2024

Clin Colon Rectal Surg

Self Cite

View full text Add to dashboard Cite

Sexual and gender minorities (SGMs) experience critical barriers to health care access and have unique health care needs that are often overlooked. Given the rise in individuals identifying as lesbian, gay, bisexual, transgender, and queer, colorectal surgeons are likely to care for increasing numbers of such individuals. Here, we discuss key barriers to health care access and research among SGM populations and outline approaches to address these barriers in clinical practice. We also highlight two specific topics relevant to SGM populations that colorectal surgeons should be familiar with: current approaches to anal cancer screening among men who have sex with men, and transgender individuals, as well as the management of recto-neovaginal fistula in transfeminine individuals.

show abstract

Missing, Inconsistent, and Other—A Call to Improve Transgender Representation in Oncology Research

Cited by 4 publications

References 3 publications

Diversity in Cancer Care

Diversity in Cancer Care

“Prostatectomy after gender-affirming vaginoplasty for a transgender woman with prostate cancer”

Considerations for the Treatment of Sexual and Gender Minority Individuals in Colon and Rectal Surgery

Contact Info

Product

Resources

About